🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📰 NEWS: Ceri-Anne Maggs has been appointed as the second Mesothelioma UK Clinical Nurse Specialist in Wales, based at the St Woolos Hospital in Newport, part of the Aneurin Bevan University Health Board 🔗Read more here: oncologynewstoday.co.uk/ceri-anne-magg…

Last week, 4 #lungcancer advocates from LuCE member organisations took part in WECAN Academy 2025 - a European training programme for cancer advocacy. From HTA to clinical trials to the lived reality of pushing for better access, it was a full-on few days of learning,

👋Do you work with communities in Greater Manchester? If so you could help us to raise awareness about the signs and symptoms of cancer. See our July Cancer Campaign Resource Update and subscribe: content.govdelivery.com/accounts/UKNHS… #CancerAwareness

📰 NEWS: A leading UK charity has warned thousands of people with incurable secondary #breastcancer in England, Wales and Northern Ireland face being denied treatments that would keep them alive 🔗 Read more here: oncologynewstoday.co.uk/uk-charity-sou…

📰 NEWS: Cancer Research Horizons has appointed its first Clinical Advisory Board to provide strategic guidance on the development of novel #cancer therapeutics emerging from its drug discovery division, Therapeutic Innovation 🔗 Read more here: oncologynewstoday.co.uk/cancer-researc…

Professor Agnieszka Michael, NOCA Clinical Lead, will speak at #BGCS2025 conference, presenting key findings from upcoming 2025 State of the Nation report (publication on 11th Sept) and sharing insights on the NOCA QI intervention! Healthcare Quality Improvement Partnership National Cancer Audit Collaborating Centre Sudha Sundar Target Ovarian Cancer

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C) thelancet.com/journals/lanon… The phase 3 PACE-C trial compared early toxicity between moderately hypofractionated radiotherapy (MHRT) and stereotactic body

Fit for the future: 10 Year Health Plan for England - executive summary - GOV.UK gov.uk/government/pub…

NIVO + IPI vs NIVO for MSI-H/dMMR mCRC: Health-related quality of life analysis 🔎CheckMate 8HW 👉mPFS clearly improved 👉 HRQoL, less symptoms 🧐 Supports use of Nivo IPI as 1st line treatment in MSI CRC #ESMOAmbassadors #ESMOGI25 ESMO - Eur. Oncology

On-demand TACE + with Atezo+Bev or TACE alone in intermediate-to-high burden HCC 🔎TALENTACE phase III 👉ORR 49 vs 34% 👉mPFS 11.3 vs 7.03 👉mOS 34 vs 25 mo 🧐 In line with LEAP-12 & EMERALD-1, still no mature OS data, supportive #ESMOAmbassadors #ESMOGI25 ESMO - Eur. Oncology

People with #lungcancer & low BMI are more likely to develop brain metastases - a link not seen in other cancers. New open access study in Nature Communications, July 2025. Researchers suggest it’s driven by brain signalling changes, not just weight loss. 🔗

🧪 Fundraising Friday Your donations fund research that saves lives. We’ve supported 45+ research grants tackling diagnosis, treatment & recovery for head & neck cancer. 💜 Fund the future: loom.ly/Yfx6pZU #FundraisingFriday #OracleHNCUK #CancerResearch #KnowYourNorm

🎗️ July = Sarcoma Awareness Month 📊 Over 50 types of sarcoma exist 🧬 It can affect anyone, at any age Let’s raise awareness for this rare cancer and support those fighting it. Sarcoma UK

💫🌟🚨 BREAKING: Imfinzi approved in the EU 🇪🇺🌟💫 🔵 First & only perioperative immunotherapy for resectable MIBC! Tom Powles AstraZeneca OncoAlert Based on #NIAGARA Phase III: ✔️ 32% ↓ recurrence risk ✔️ 25% ↓ mortality risk ✔️ >80% alive at 2 years ✔️ ESMO-MCBS: Grade A

📰 NEWS: A new mechanism by which B cells use a cellular recycling process to control changes to their DNA essential for antibody improvement has been discovered which could have implications for the development of certain #bloodcancers 🔗Read more here: oncologynewstoday.co.uk/cells-recyclin…

📰 NEWS: Researchers in Sheffield are working to develop a blood test which could predict the likelihood of #breastcancer spreading to the bone and becoming incurable, thanks to new funding from Breast Cancer Now 🔗 Read more here: oncologynewstoday.co.uk/breast-cancer-…

📰 NEWS: Consultant medical #oncologist Professor Matt Winter from Sheffield Teaching Hospitals NHS Foundation Trust has become the new President of the European Organisation for Treatment of Trophoblastic Diseases 🔗 Read more here: oncologynewstoday.co.uk/sheffield-canc…

📰 NEWS: A glowing report into the south west #radiotherapy late effects service has been published this week 🔗 Read more here: oncologynewstoday.co.uk/south-west-rad…

📰 NEWS: A #cancer expert who prolonged the life of the inspirational author and charity founder, Mick May, has received a £100,000 donation to help continue his ground breaking work University of Leicester 🔗 Read more here: oncologynewstoday.co.uk/cancer-expert-…